M.I.T

Barnes Announces Update to Board of Directors

Retrieved on: 
Tuesday, March 5, 2024
Engineering, Chemicals, Plastics, Aerospace, Manufacturing, Other Manufacturing, Steel, Spirit AeroSystems, Diving, LMT, Operating partner, Barnes Group, Barnes Foundation, M.I.T, Lawrence Technological University, Confidentiality, University, Harvard University, Retirement, Harvard Law School, Foundation (nonprofit), Lead, Advent International, BofA Securities, Family, Latin honors, Security (finance), Electricity, Harvard Business School, Lockheed Martin, SPR, Management

Mr. Barnes will become Chairman Emeritus and continue to lead the Barnes Foundation following his retirement from the Board.

Key Points: 
  • Mr. Barnes will become Chairman Emeritus and continue to lead the Barnes Foundation following his retirement from the Board.
  • Barnes will also work with Irenic to identify an additional mutually agreed upon independent director to appoint to the Board of Directors.
  • Thomas O. Barnes, Chairman of the Board, said, “It has been an honor to serve the company my family founded in 1857.
  • On behalf of the Board and the entire Barnes team, I want to thank Mylle for her service and wish her all the best going forward.”
    Barnes added, “I am delighted that the Board has selected Dick as my successor as Chair of our Board of Directors.

FloraWorks Appoints Cannabis Scientist Dr. Mike McCormick as VP of Strategy

Retrieved on: 
Wednesday, October 4, 2023
National academy, Therapy, Doctor of Philosophy, ARCH Venture Partners, Cannabinoid, IP, Science, Sleep, Chemistry, CBN, Cannabinol, Publication, M.I.T, Scripps Research, Entrepreneurship, Health, Safety, Pharmaceutical industry, Nature, Biochemistry

Portland, Oregon--(Newsfile Corp. - October 4, 2023) - FloraWorks Holdings Inc. , a leading cannabinoid therapeutics company, announced the appointment of Dr. Mike McCormick as VP of Strategy.

Key Points: 
  • Portland, Oregon--(Newsfile Corp. - October 4, 2023) - FloraWorks Holdings Inc. , a leading cannabinoid therapeutics company, announced the appointment of Dr. Mike McCormick as VP of Strategy.
  • A science and intellectual property consultant for FloraWorks since 2022, Dr. McCormick brings extensive expertise in cannabinoid biochemistry, innovation, and IP protection.
  • Within the cannabis industry, Dr. McCormick focuses on industrial and academic technology transfer, and the development of next-generation therapeutics, consumer products, scientific methods, and educational content.
  • "We are thrilled to welcome Dr. McCormick to the leadership team during this momentous time for our company," said Alleh Lindquist , CEO and Co-Founder of FloraWorks.

Acorda Therapeutics and Chance Pharmaceuticals Announce Agreement to Commercialize INBRIJA® in China

Retrieved on: 
Monday, May 8, 2023
Seniors, Neurology, Other Health, Biotechnology, Baby Boomers, Pharmaceutical, Consumer, Health, Supply Chain Management, Retail, PD, CMC, Ageing, Acorda Therapeutics, Açorda, Medication, Parkinson's disease, Patient, AIR, M.I.T, OFF, Therapy, Pharmaceutical industry, Chance, Alkermes

Acorda Therapeutics, Inc. (Nasdaq: ACOR) and Hangzhou Chance Pharmaceuticals Co. Ltd. today announced that they have entered into distribution and supply agreements to provide INBRIJA® in China.

Key Points: 
  • Acorda Therapeutics, Inc. (Nasdaq: ACOR) and Hangzhou Chance Pharmaceuticals Co. Ltd. today announced that they have entered into distribution and supply agreements to provide INBRIJA® in China.
  • By 2030, it is estimated that China will have approximately 5 million people with Parkinson’s diseasedue to its aging population1.
  • “Our agreement with Chance is an important milestone toward providing INBRIJA to the world’s largest population of people with Parkinson’s.
  • “We are excited to be collaborating with Acorda to make INBRIJA available to people suffering from Parkinson’s disease in China.

Chance Pharmaceuticals and Acorda Therapeutics Announce Agreement to Provide INBRIJA® in Greater China

Retrieved on: 
Monday, May 8, 2023
PD, CMC, Ageing, Açorda, Acorda Therapeutics, Medication, Parkinson's disease, Patient, AIR, M.I.T, OFF, Therapy, Pharmaceutical industry, Mainland China, Chance, Alkermes

HANGZHOU, China, May 8, 2023 /PRNewswire/ -- Chance Pharmaceuticals and Acorda Therapeutics, Inc. today announced that they have entered into distribution and supply agreements to provide INBRIJA® in Greater China (Mainland China, Taiwan, Hong Kong, and Macao).

Key Points: 
  • HANGZHOU, China, May 8, 2023 /PRNewswire/ -- Chance Pharmaceuticals and Acorda Therapeutics, Inc. today announced that they have entered into distribution and supply agreements to provide INBRIJA® in Greater China (Mainland China, Taiwan, Hong Kong, and Macao).
  • "We are excited to be collaborating with Acorda to make INBRIJA available to people suffering from Parkinson's disease in China.
  • "Our agreement with Chance is an important milestone toward providing INBRIJA to the world's largest population of people with Parkinson's.
  • The Chance team are experts in inhalation technologies, and we look forward to working with them to achieve regulatory approval and to provide this important medication to patients in China," said Ron Cohen, M.D., President and CEO of Acorda Therapeutics.

Akston Biosciences Strengthens Board with Addition of John T. Preston

Retrieved on: 
Monday, January 23, 2023
Biotechnology, General Health, Infectious Diseases, Health, Pharmaceutical, Clean Harbors, Mars, Incorporated, M.I.T, MIT, Research, Preston, Massachusetts Institute of Technology, National Merit Scholarship Program, Martek Biosciences Corporation, Government, Congress, Associate, Multimedia, Rivian, Pharmaceutical industry, Management

Akston Biosciences Corporation, a clinical-stage biotechnology company, today announced that John T. Preston, a founder of TEM Capital, has joined its Board of Directors.

Key Points: 
  • Akston Biosciences Corporation, a clinical-stage biotechnology company, today announced that John T. Preston, a founder of TEM Capital, has joined its Board of Directors.
  • A recipient of numerous awards and previous advisor to several government agencies and expert witness for Congress, Preston brings to Akston his decades of experience in technology commercialization and intellectual property licensing.
  • View the full release here: https://www.businesswire.com/news/home/20230123005251/en/
    John T. Preston, a founder of TEM Capital, and a recipient of numerous awards and advisor to several government agencies, has joined Akston Biosciences' Board of Directors.
  • He also has served as a director of four public companies, including Clean Harbors, and as a Board Advisor to Mars Incorporated.

Spectaire Inc., Innovative Emissions Monitoring Provider, to Go Public via Business Combination with Perception Capital Corp. II

Retrieved on: 
Tuesday, January 17, 2023
Professional Services, Business, Technology, Other Professional Services, Other Technology, Finance, Slate, MMS, Trust, Pressure, Latham & Watkins, Carbon, LLP, ESG, Skadden, M.I.T, Perception, Renewable energy, Sales

Companies required to report carbon emissions throughout their supply chain must accurately measure the effect of their emissions mitigation strategies.

Key Points: 
  • Companies required to report carbon emissions throughout their supply chain must accurately measure the effect of their emissions mitigation strategies.
  • Spectaire’s direct measurement technology replaces current methods of “estimating” emissions based on mileage and fuel consumption, which can overstate emissions by up to 60%.
  • Invented and patented by Spectaire scientists at M.I.T., Spectaire’s MMS device is battery-powered, cloud-connected and about the size of a small tablet.
  • They need tools to accurately track and report emissions in real time, and to reduce emissions, we must first accurately measure emissions.

Presto Voice Brings Custom Voices to Enhance Automated Drive-Thru Guest Experience

Retrieved on: 
Thursday, December 15, 2022
Software, Mobile, Wireless, Networks, Restaurant, Bar, Hardware, Data Management, Apps, Applications, Technology, Artificial Intelligence, Retail, Audio, Video, Other Technology, Human voice, Privacy, Intellectual property, Silicon, Human, Security (finance), A.I, Vision, Restaurant, M.I.T, Ageing, Tax, Growth, Investment, Food, Automation, Colonel Sanders, Mobile phone, Online shopping, Phonograph record, Customer service, COVID-19

Presto Voice is currently the industrys most widely adopted A.I.-powered drive-thru voice assistant with over 75% market share.

Key Points: 
  • Presto Voice is currently the industrys most widely adopted A.I.-powered drive-thru voice assistant with over 75% market share.
  • The unique experiences enabled by this new Presto Voice feature include:
    Celebrity Voices: Guests can experience drive-thru voice ordering by conversing with a celebrity, whose voice would be programmed to know the whole menu.
  • Limitless Flexibility: The voice customization feature in Presto Voice is very flexible, offering limitless customizations in practically any voice.
  • And the new custom voice feature is expected to significantly enhance the guest experience and make drive-thru ordering delightful for visitors.

Angel Gold Announces Proposed Name Change to Eon Lithium Corp., Board of Directors and Management Changes & Change of Auditor

Retrieved on: 
Thursday, December 8, 2022
M.I.T, Interim, Mining, TSX Venture Exchange, Business, Industrial engineering, Interim management, CUSIP, Chartered Professional Accountant, ISIN, News, SHIM, Acquisition, Patent, Engineering, Cryptocurrency, Management, Lithium, Audit

Additionally, Angel Gold is pleased to announce the appointment of Fernando Erik Villarroel Alcocer as President, Interim CEO and a director, effective November 30, 2022.

Key Points: 
  • Additionally, Angel Gold is pleased to announce the appointment of Fernando Erik Villarroel Alcocer as President, Interim CEO and a director, effective November 30, 2022.
  • Mr. Villarroel has 12 years of experience in the mining industry in Argentina with a focus on Lithium process development.
  • The board of directors of the Company thanks Mr. Cherry for his managing of the recent acquisition of the Amanecer Lithium Project, located in Argentina.
  • Angel Gold Corp. (name change to Eon Lithium Corp. pending) is a lithium brine project and lithium extraction technology developer located in Salta, Argentina.

Presto to Report First Quarter 2023 Financial Results on November 15, 2022

Retrieved on: 
Friday, November 11, 2022
Technology, Other Technology, M.I.T, Webcast, Company, Industry, Silicon, Telephone, Online shopping

Presto Automation Inc. (Nasdaq: PRST), one of the largest labor automation technology providers in the hospitality industry, today announced that the Company will release its first quarter 2023 financial results on Tuesday, November 15, 2022 after the financial markets close.

Key Points: 
  • Presto Automation Inc. (Nasdaq: PRST), one of the largest labor automation technology providers in the hospitality industry, today announced that the Company will release its first quarter 2023 financial results on Tuesday, November 15, 2022 after the financial markets close.
  • The Company will host a conference call that same day to discuss its results and business outlook at 4:30 p.m. Eastern time.
  • The call will be accessible by telephone at 877-407-0792 (domestic) or 201-689-8263 (international) using passcode 13733666.
  • With over 300 million transactions processed, Presto is one of the largest labor automation technology providers in the industry.

Toll Brothers Apartment Living® Hosts Grand Opening of Emblem 120, Firm’s New Luxury Mid-Rise Apartment Community in Woburn, Mass.

Retrieved on: 
Tuesday, October 11, 2022
Logan International Airport, M.I.T, EV, Emblem, Builder, Engineering, NYSE, Cube, Kendrick, Company, Television, GLOBE, Cube Zero, New, Lyra, Toll Brothers, List of highways numbered 93, Technology, Harvard University, Downtown Boston, Professional Builder, NMHC, Culture, Laurent, Assistant, List of highways numbered 128, District, Entrepreneurship, Hotel, Nightclub, Greater Boston

BOSTON, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Toll Brothers Apartment Living , the rental subsidiary of Toll Brothers, Inc .

Key Points: 
  • BOSTON, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Toll Brothers Apartment Living , the rental subsidiary of Toll Brothers, Inc .
  • As our newest luxury project in the Greater Boston metropolitan area, Emblem 120 marks the fourth project Toll Brothers Apartment Living has undertaken in the region and joins our growing portfolio of luxury rental communities across New England, said Charles Elliott, President of Toll Brothers Apartment Living.
  • Toll Brothers Apartment Living is the apartment development division of Toll Brothers, Inc. (NYSE: TOL), an award-winning FORTUNE 500 company, and the nation's leading builder of luxury homes.
  • In 2022, NMHC ranked Toll Brothers Apartment Living the 11th largest apartment developer in the United States.